Functional MRI markers for treatment-resistant depression: Insights and challenges

Vasileia Kotoula1, Jennifer W Evans1, Claire Punturieri1

  • 1Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Bethesda, MD, United States.

PubMed
Summary

Neuroimaging reveals altered brain connectivity and metabolites in treatment-resistant depression (TRD). Interventions like TMS show promise in reversing these changes, but more research is needed for definitive conclusions.